Bellerophon Therapeutics, Inc.
BLPH · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,382 | $10,575 | $15,172 | $6,924 |
| Short-Term Investments | $0 | $0 | $0 | $405 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $597 | $670 | $599 | $234 |
| Total Curr. Assets | $4,979 | $11,245 | $15,771 | $7,563 |
| Property Plant & Equip (Net) | $0 | $0 | $9 | $186 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $186 | $186 |
| Total NC Assets | $0 | $0 | $195 | $372 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,979 | $11,245 | $15,966 | $7,935 |
| Liabilities | – | – | – | – |
| Payables | $612 | $1,887 | $1,070 | $1,230 |
| Short-Term Debt | $0 | $0 | $16 | $203 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $644 | $3,735 | $4,278 | $3,968 |
| Total Curr. Liab. | $1,256 | $5,622 | $5,364 | $5,401 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $4,286 | $0 |
| Other Liabilities | $0 | $0 | -$4,286 | $0 |
| Cap. Leases | $0 | $0 | $8 | $203 |
| Total Liabilities | $1,256 | $5,622 | $5,364 | $5,401 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $122 | $122 | $104 | $96 |
| Retained Earnings | -$256,315 | -$254,394 | -$249,256 | -$252,078 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $259,916 | $259,895 | $259,754 | $254,516 |
| Total Equity | $3,723 | $5,623 | $10,602 | $2,534 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,979 | $11,245 | $15,966 | $7,935 |
| Net Debt | -$4,382 | -$10,575 | -$15,156 | -$6,721 |